Bernd Schmidt
Chief Tech/Sci/R&D Officer bij SENSORION
Actieve functies van Bernd Schmidt
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| SENSORION | Chief Tech/Sci/R&D Officer | 11-12-2023 | - |
Loopbaan van Bernd Schmidt
Eerdere bekende functies van Bernd Schmidt
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Quell Therapeutics Ltd.
 Quell Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Quell Therapeutics Ltd. is a London-based biotechnology company, which develops immune cell therapies to target transplant rejection, autoimmune and inflammatory diseases. It develops engineered T regulatory cell therapies for a variety of non-cancer targets. The company was founded on March 19, 2019 and is headquartered in London, the United Kingdom. | Corporate Officer/Principal | - | - |
Opleiding van Bernd Schmidt
| Friedrich-Alexander University of Erlangen-Nuremberg | Graduate Degree |
Statistieken
Internationaal
| Duitsland | 2 |
| Frankrijk | 2 |
| Verenigd Koninkrijk | 2 |
Operationeel
| Graduate Degree | 1 |
| Corporate Officer/Principal | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
Sectoraal
| Health Technology | 3 |
| Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| SENSORION | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Quell Therapeutics Ltd.
Quell Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Quell Therapeutics Ltd. is a London-based biotechnology company, which develops immune cell therapies to target transplant rejection, autoimmune and inflammatory diseases. It develops engineered T regulatory cell therapies for a variety of non-cancer targets. The company was founded on March 19, 2019 and is headquartered in London, the United Kingdom. | Health Technology |
- Beurs
- Insiders
- Bernd Schmidt
- Ervaring
